Innovacell Biotechnologie

Developer of cell-treatment for the treatment of incontinence

placeInnsbruck, Tyrol, Austria calendar_todayFounded 2000 groups22 employees language innovacell.at

Innovation

4 patent families (2 granted) — focus: Human necessities; filing pace dormant. Cited 96 times.

YearFilings
20132

Investor mix

7 investors on record; lead investors include Uni-Venture, Buschier, Fides, Alpine Equity.

Investor typeCountShare
Venture capital114%
Private equity229%
Other / undisclosed457%
Coming soon